Capital Investment Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$101M Sell
414,005
-32,400
-7% -$7.55M 1.48% 10
2025
Q4
$92.4M Buy
446,405
+6,323
+1% +$1.25M 1.41% 12
2025
Q3
$81.6M Buy
440,082
+5,517
+1% +$945K 1.34% 14
2025
Q2
$66.4M Buy
434,565
+9,532
+2% +$1.47M 1.19% 20
2025
Q1
$70.5M Buy
425,033
+16,620
+4% +$2.6M 1.38% 13
2024
Q4
$59.1M Sell
408,413
-7,335
-2% -$1.14M 1.2% 19
2024
Q3
$67.4M Buy
415,748
+18,303
+5% +$2.92M 1.39% 12
2024
Q2
$58.1M Buy
397,445
+2,767
+0.7% +$412K 1.31% 15
2024
Q1
$62.4M Sell
394,678
-1,027
-0.3% -$163K 1.46% 11
2023
Q4
$62M Sell
395,705
-8,767
-2% -$1.34M 1.56% 13
2023
Q3
$63M Buy
+404,472
New +$66.7M 1.74% 12
2023
Q2
Sell
-298,984
Closed -$46.3M 575
2023
Q1
$46.3M Sell
298,984
-2,512
-0.8% -$406K 1.37% 14
2022
Q4
$53.3M Buy
301,496
+5,462
+2% +$943K 1.61% 11
2022
Q3
$48.4M Buy
296,034
+7,771
+3% +$1.32M 1.66% 11
2022
Q2
$51.2M Buy
288,263
+7,439
+3% +$1.33M 1.7% 11
2022
Q1
$49.8M Buy
280,824
+4,352
+2% +$741K 1.52% 13
2021
Q4
$47.3M Buy
276,472
+5,036
+2% +$824K 1.44% 16
2021
Q3
$43.8M Buy
271,436
+3,753
+1% +$640K 1.48% 15
2021
Q2
$44.1M Buy
267,683
+4,715
+2% +$781K 1.52% 14
2021
Q1
$43.2M Buy
262,968
+4,611
+2% +$746K 1.63% 13
2020
Q4
$40.7M Buy
258,357
+8,320
+3% +$1.23M 1.7% 12
2020
Q3
$37.2M Buy
250,037
+5,659
+2% +$837K 1.78% 10
2020
Q2
$34.4M Buy
244,378
+6,607
+3% +$963K 1.78% 10
2020
Q1
$31.2M Buy
237,771
+71,597
+43% +$10.2M 1.99% 7
2019
Q4
$24.2M Buy
166,174
+6,066
+4% +$823K 1.17% 21
2019
Q3
$20.7M Buy
160,108
+4,991
+3% +$658K 1.09% 20
2019
Q2
$21.6M Buy
155,117
+242
+0.2% +$33.5K 1.18% 21
2019
Q1
$21.6M Sell
154,875
-129
-0.1% -$17.3K 1.26% 17
2018
Q4
$20M Sell
155,004
-27,004
-15% -$3.77M 1.33% 14
2018
Q3
$25.1M Buy
182,008
+2,784
+2% +$370K 1.48% 12
2018
Q2
$21.7M Buy
179,224
+35,778
+25% +$4.46M 1.35% 13
2018
Q1
$18.4M Buy
143,446
+7,318
+5% +$989K 1.2% 15
2017
Q4
$19M Sell
136,128
-894
-0.7% -$125K 1.24% 14
2017
Q3
$17.8M Sell
137,022
-816
-0.6% -$108K 1.22% 15
2017
Q2
$18.2M Buy
137,838
+25,761
+23% +$3.29M 1.31% 13
2017
Q1
$14M Buy
112,077
+6,643
+6% +$794K 1.06% 19
2016
Q4
$12.1M Sell
105,434
-9,136
-8% -$1.06M 1.02% 16
2016
Q3
$13.5M Buy
114,570
+3,753
+3% +$455K 1.19% 16
2016
Q2
$13.4M Buy
110,817
+7,853
+8% +$892K 1.26% 15
2016
Q1
$11.1M Buy
102,964
+11,892
+13% +$1.23M 1.1% 17
2015
Q4
$9.36M Buy
91,072
+14,010
+18% +$1.41M 0.96% 24
2015
Q3
$7.19M Buy
77,062
+7,257
+10% +$702K 0.81% 29
2015
Q2
$6.8M Buy
69,805
+443
+0.6% +$44.4K 0.73% 30
2015
Q1
$6.98M Sell
69,362
-134
-0.2% -$13.6K 0.74% 31
2014
Q4
$7.27M Buy
69,496
+362
+0.5% +$38.1K 0.8% 30
2014
Q3
$7.37M Buy
69,134
+6,843
+11% +$710K 0.84% 28
2014
Q2
$6.52M Sell
62,291
-1,859
-3% -$188K 0.75% 32
2014
Q1
$6.3M Buy
64,150
+225
+0.4% +$20.9K 0.79% 27
2013
Q4
$5.86M Buy
+63,925
New +$5.89M 0.78% 28

Other funds holding JNJ

Capital Investment Advisors's JNJ Position: Q1 2026 in Review

Capital Investment Advisors reduced its Johnson & Johnson (JNJ) stake by 7.3% in Q1 2026, selling an estimated $7.55M and leaving 414,005 shares worth $101M. The position accounts for 1.48% of the portfolio, ranked #10.

Capital Investment Advisors first reported a position in JNJ in Q4 2013 and has held it in 49 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Capital Investment Advisors held 414,005 shares of Johnson & Johnson worth $101M as of Q1 2026.
  • Capital Investment Advisors sold 32,400 Johnson & Johnson shares in Q1 2026, an estimated $7.55M.
  • Johnson & Johnson made up 1.48% of Capital Investment Advisors's portfolio in Q1 2026, its #10 holding.
  • Capital Investment Advisors first reported a position in Johnson & Johnson in Q4 2013 and has held it in 49 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Capital Investment Advisors's 13F filing for Q1 2026, filed 16 Apr 2026.